$RMNI
Rimini Street, Inc.

2016 Q3 Form 10-Q Financial Statement

#000114420416134710 Filed on November 15, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q4 2015 Q3
Revenue $40.72M $118.2M $0.00
YoY Change
Cost Of Revenue $17.23M $52.80M
YoY Change
Gross Profit $23.49M $65.40M
YoY Change
Gross Profit Margin 57.69% 55.33%
Selling, General & Admin $26.92M $74.60M $100.0K
YoY Change 26817.0%
% of Gross Profit 114.58% 114.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.450M
YoY Change
% of Gross Profit 2.22%
Operating Expenses $26.92M $74.50M $100.0K
YoY Change 26817.0%
Operating Profit -$4.506M -$9.100M -$81.16K
YoY Change 5451.86%
Interest Expense $4.317M -$900.0K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$144.0K -$1.100M
YoY Change
Pretax Income -$15.09M -$43.90M -$100.0K
YoY Change 14985.0%
Income Tax -$306.0K $1.500M
% Of Pretax Income
Net Earnings -$15.39M -$45.30M -$51.83K
YoY Change 29596.88%
Net Earnings / Revenue -37.79% -38.32%
Basic Earnings Per Share -$0.63
Diluted Earnings Per Share -$0.63 -$537.4K -$18.87K
COMMON SHARES
Basic Shares Outstanding 24.26M shares
Diluted Shares Outstanding 24.26M shares

Balance Sheet

Concept 2016 Q3 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $1.000M $1.000M
YoY Change -100.0%
Cash & Equivalents $2.470K $967.4K $1.046M
Short-Term Investments
Other Short-Term Assets $200.0K $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses $233.9K $7.951K $15.31K
Receivables
Other Receivables
Total Short-Term Assets $236.4K $975.4K $1.100M
YoY Change -78.51%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $173.0M $172.6M $172.6M
YoY Change 0.23%
Total Long-Term Assets $173.0M $172.6M $172.5M
YoY Change 0.26%
TOTAL ASSETS
Total Short-Term Assets $236.4K $975.4K $1.100M
Total Long-Term Assets $173.0M $172.6M $172.5M
Total Assets $173.2M $173.6M $173.6M
YoY Change -0.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $0.00 $0.00
YoY Change
Accrued Expenses $379.7K $19.97K $20.33K
YoY Change 1767.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.600M $19.97K $6.100M
YoY Change 24.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.600M $19.97K $6.100M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $7.610M $6.057M $6.058M
YoY Change 25.62%
SHAREHOLDERS EQUITY
Retained Earnings -$2.028M -$130.7K -$59.20K
YoY Change 3325.66%
Common Stock $554.00 $532.00 $531.00
YoY Change 4.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.000M -$212.3M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $173.2M $173.6M $173.6M
YoY Change -0.24%

Cashflow Statement

Concept 2016 Q3 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$15.39M -$45.30M -$51.83K
YoY Change 29596.88%
Depreciation, Depletion And Amortization $1.450M
YoY Change
Cash From Operating Activities -$940.0K $1.690M -$70.00K
YoY Change 1242.86%
INVESTING ACTIVITIES
Capital Expenditures -$1.750M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $170.8M $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 800.0K -174.5M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -940.0K 1.690M -70.00K
Cash From Investing Activities 0.000 170.8M 0.000
Cash From Financing Activities 800.0K -174.5M 0.000
Net Change In Cash -140.0K -2.060M -70.00K
YoY Change 100.0%
FREE CASH FLOW
Cash From Operating Activities -$940.0K $1.690M -$70.00K
Capital Expenditures -$1.750M
Free Cash Flow $3.440M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
233917 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
5000001 USD
CY2016Q3 us-gaap Liabilities
Liabilities
7609879 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2470 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
236387 USD
CY2016Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
172972482 USD
CY2016Q3 us-gaap Assets
Assets
173208869 USD
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
379743 USD
CY2015Q4 us-gaap Deferred Long Term Liability Charges
DeferredLongTermLiabilityCharges
6037500 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
554 USD
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7027367 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2027920 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
173208869 USD
CY2016Q3 us-gaap Deferred Long Term Liability Charges
DeferredLongTermLiabilityCharges
6037500 USD
CY2016Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
160598989 USD
CY2015Q4 us-gaap Liabilities
Liabilities
6057468 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130726 USD
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1192636 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5130195 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
532 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2291424 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-402948 USD
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
55234 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-347057 USD
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2016Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
402948 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-81162 USD
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
29335 USD
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2016Q3 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
657 USD
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5303868 shares
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
359775 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
225966 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2157615 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1192636 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1045663 USD
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
85000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
100000 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
25000 USD
gpiau Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
1897194 USD
gpiau Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
49849 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
172500000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-172500000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
146250000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
6062500 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
21937500 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
86321 USD
CY2015Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
162496183 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-51827 USD
CY2015Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
81162 USD
CY2015Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
393573 USD
us-gaap Net Income Loss
NetIncomeLoss
-1897194 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2291424 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
123764 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-123764 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
64566 USD
us-gaap Net Income Loss
NetIncomeLoss
-59198 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
657 USD
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
0 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4555028 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-118747 USD
CY2015Q3 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
0 USD
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5506671 shares
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1192636 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-964979 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
15312 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
20329 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
525590 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1321 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
173664410 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1045663 USD
CY2015Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 USD
CY2016Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
16016030 shares
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
100000 USD
gpiau Initial Classification Of Ordinary Shares Subject To Possible Redemption
InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption
0 USD
gpiau Initial Classification Of Ordinary Shares Subject To Possible Redemption
InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption
162617560 USD
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
CY2016Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2015Q2 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
10000 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
gpiau Deferred Underwriting Fees
DeferredUnderwritingFees
0 USD
gpiau Deferred Underwriting Fees
DeferredUnderwritingFees
6037500 USD
CY2015Q2 gpiau Common Units Issued In Initial Public Offering
CommonUnitsIssuedInInitialPublicOffering
17250000 shares
CY2015Q2 us-gaap Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
10960590 USD
CY2015Q2 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
4312500 USD
CY2015Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
6037500 USD
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2015-01-28
gpiau Interest On Dissolution Expenses
InterestOnDissolutionExpenses
100000 USD
gpiau Reduction Of Intangible Assets Due To Redemption
ReductionOfIntangibleAssetsDueToRedemption
5000001 USD
us-gaap Interest Income Other
InterestIncomeOther
472000 USD
CY2016Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
500000 USD
CY2016Q3 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
172972482 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
14687500 shares
CY2016Q3 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
30000 USD
CY2016Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 USD
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
90000 USD
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
50000 USD
CY2016Q3 gpiau Working Capital Loan
WorkingCapitalLoan
1000000 USD
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5546470 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2016Q3 gpiau Contingent Transaction Fee Amount
ContingentTransactionFeeAmount
3943000 USD
CY2015Q2 gpiau Underwriters Discount Percentage
UnderwritersDiscountPercentage
0.060 pure
CY2015Q2 gpiau Payments To Underwriters In Cash
PaymentsToUnderwritersInCash
4312500 USD
CY2015Q2 gpiau Underwriters Deferred Discount Amount
UnderwritersDeferredDiscountAmount
6037500 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
GP Investments Acquisition Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001635282
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Trading Symbol
TradingSymbol
GPIAU
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21562500 shares
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5320250 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5546470 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5320250 shares
CY2015Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
16242250 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>Use of estimates</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
16250688 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>Concentration of credit risk</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. At September 30, 2016, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD

Files In Submission

Name View Source Status
0001144204-16-134710-index-headers.html Edgar Link pending
0001144204-16-134710-index.html Edgar Link pending
0001144204-16-134710.txt Edgar Link pending
0001144204-16-134710-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gpiau-20160930.xml Edgar Link completed
gpiau-20160930.xsd Edgar Link pending
gpiau-20160930_cal.xml Edgar Link unprocessable
gpiau-20160930_def.xml Edgar Link unprocessable
gpiau-20160930_lab.xml Edgar Link unprocessable
gpiau-20160930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v451101_10q.htm Edgar Link pending
v451101_ex31.htm Edgar Link pending
v451101_ex32.htm Edgar Link pending